OUPS: Assessing the Impact of Clown Therapy in a Palliative Care Unit: A Prospective, Descriptive Study

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT02610452
Collaborator
(none)
30
1
1
7.4
4

Study Details

Study Description

Brief Summary

The main objective of this study was to assess changes in the quality of life of patients in a Palliative Care Unit via the symptoms by the Edmonton Symptom Assessment System (ESAS) before and one hour after the passage of a clown therapist .

Condition or Disease Intervention/Treatment Phase
  • Other: Clown therapy
N/A

Detailed Description

The secondary objectives of this study are to evaluate before versus after the intervention of clowns therapists:

  1. Changes in the quality of life at two days after the intervention (using the ESAS).

  2. The quality of life two days after the intervention via the McGill Quality of Life Questionnaire.

  3. The quality of life of patients after the intervention as assessed by semi-structured interviews conducted by the department psychologist.

  4. The quality of life of caregivers after the intervention as assessed by semi-structured interviews conducted by the department psychologist.

  5. Employee satisfaction at the end of the intervention period in the department and after debriefing as assessed by semi-structured interviews conducted by the department psychologist.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Assessing the Impact of Clown Therapy in a Palliative Care Unit: A Prospective, Descriptive Study
Actual Study Start Date :
Mar 31, 2016
Actual Primary Completion Date :
Nov 12, 2016
Actual Study Completion Date :
Nov 12, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: The study population

The study population consists of adult patients treated in the Palliative Care Unit of the University Hospital of Nimes, regardless of their original condition. In 2013 the proportion of stays connected with diagnostics for cancer was 70.16%. Intervention: Clown therapy

Other: Clown therapy
The clowns intervene by twos: a game takes place. The game requires the active presence of a number of potential players in the room (patient, family, caregivers) and takes into account body position, emotional state, the general atmosphere. The clowns initiate a game proposal: provisional staging of clown characters based on imagination/improvisation which engages a physicality and a basic emotional state. The original game proposal is adjusted according to mutual empathy with those present. The game is developed on the model of theatrical improvisation: an original creation that has "scenic" quality comparable to that of a complete representation. Improvisation time varies depending on the condition of the person, his/her desire to participate, choosing the main theme. The final stage of the game is preparing all actors for separation: restitution of roles, revisiting the paths traveled.

Outcome Measures

Primary Outcome Measures

  1. ESAS questionnaire [1 hour before clown therapy session]

    The ESAS (Edmonton Symptom Assessment System) self-administered questionnaire

  2. ESAS questionnaire [1 hour after clown therapy session]

    The ESAS (Edmonton Symptom Assessment System) self-administered questionnaire

  3. ESAS questionnaire [Day 2]

    The ESAS (Edmonton Symptom Assessment System) self-administered questionnaire

Secondary Outcome Measures

  1. McGill Quality of Life Questionnaire [1 hour before clown therapy session]

  2. McGill Quality of Life Questionnaire [Day 2]

  3. Semi-directed patient interview [Day 2]

  4. Semi-directed caregiver interview [Day 0]

  5. Semi-directed staff interview [Day 0]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given his/her informed and signed consent

  • The patient must be insured or beneficiary of a health insurance plan

  • Patient receiving palliative care, ie with a severe and progressive disease bringing into play vital prognosis, in advanced or terminal phase

  • Clinically stable patients, regardless of disease type. The existence of clinical symptoms (pain, discomfort, etc.) found at recruitment by the investigator and not affecting the mental clarity of the subject, does not justify the exclusion of the patient

  • Absence of cognitive disorders; since the protocol provides a clinical interview covering in particular his/her quality of life, included patients will be able to express their feelings

  • In addition, patients who have undergone this type of intervention (clown therapist) will not be excluded from this study.

Exclusion Criteria:
  • The patient is participating in another study

  • The patient is an adult under judicial protection

  • The patient refuses to sign the consent

  • It is impossible to correctly inform the patient

  • Patient with an inability to fill our protocol assessment scales

  • Patients under treatment known to reduce the level of awareness

  • Patients with major cognitive impairment

  • Patients with symptoms that bring into question their level of awareness

  • Patients with significant risk factors and who should benefit from personalized monitoring from the team (clinically unstable patients, emergency situations, agitated patients, dementia, etc ...).

  • Patient is unable to submit to the continuity of the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHRU de Nîmes - Hôpital Universitaire Carémeau Nîmes Cedex 09 France 30029

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes

Investigators

  • Principal Investigator: Sylvie Blanchard, MD, Centre Hospitalier Universitaire de Nîmes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT02610452
Other Study ID Numbers:
  • LOCAL/2015/SB-01
  • 2015-A00719-40
First Posted:
Nov 20, 2015
Last Update Posted:
Jul 28, 2017
Last Verified:
Jul 1, 2017
Keywords provided by Centre Hospitalier Universitaire de Nīmes

Study Results

No Results Posted as of Jul 28, 2017